1-5 of 5
Michael Unterhalt, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab Maintenance after First-Line Immunochemotherapy in Mantle Cell Lymphoma: Long-Term Follow-up of the Randomized European MCL Elderly Trial

Eva Hoster, Hanneke Kluin-Nelemans, MD PhD, Olivier Hermine, MD PhD, Jan Walewski, MD PhD, Marek Trneny, MD, Christian H. Geisler, MD PhD, Stephan Stilgenbauer, MD PhD, Catherine Thieblemont, MD PhD, Ursula Vehling-Kaiser, MD, Jeanette K. Doorduijn, MD PhD, Lionel Karlin, MD, Roswitha Forstpointner, MD, Herve Tilly, Michal Szymczyk, MD, Vincent Ribrag, MD, Marc Andre, MD, Wolfram Klapper, MD, Wolfgang Hiddemann, Michael Unterhalt, MD PhD, Martin Dreyling, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 153.
https://doi.org/10.1182/blood.V130.Suppl_1.153.153
Published: 2017
Journal Articles

Standardized IGH-Based Next-Generation Sequencing for MRD Detection in Follicular Lymphoma

Christiane Pott, MD, PhD, Henrik Knecht, PhD, Arved Herzog, Elisa Genuardi, Michael Unterhalt, MD PhD, Barbara Mantoan, Irene Dogliotti, Wolfgang Hiddemann, MD PhD, Mario Boccadoro, Dietrich Herrmann, Michael Kneba, MD, Anton W Langerak, Nikos Darzentas, Patricia Groenen, Monika Brüggemann, MD, Eva Hoster, Marco Ladetto, Simone Ferrero
Journal: Blood
Blood (2017) 130 (Supplement 1): 1491.
https://doi.org/10.1182/blood.V130.Suppl_1.1491.1491
Published: 2017
Journal Articles

Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Is Superior to 6 Courses CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT In Mantle Cell Lymphoma: Results of the MCL Younger Trial of the European Mantle Cell Lymphoma Network ( MCL net )

Olivier Hermine, MD, PhD, Eva Hoster, Jan Walewski, Vincent Ribrag, MD, Nicole Brousse, Catherine Thieblemont, MD, Reda Bouabdallah, Stephan Stilgenbauer, M.D., Pierre Feugier, MD, PhD, Roswitha Forstpointner, MD, Corinne Haioun, MD, Michael Kneba, MD, PhD, Mathias Hänel, Rene-Olivier Casasnovas, MD, Jürgen Finke, MD, Michael Hallek, MD, Hannes Wandt, MD, Andre Bosly, MD, Wolfram Klapper, MD, Christian Gisselbrecht, MD, Bertrand Coiffier, MD, PhD, Wolfgang Hiddemann, MD, PhD, Michael Unterhalt, MD, PhD, Martin H. Dreyling, MD
Journal: Blood
Blood (2010) 116 (21): 110.
https://doi.org/10.1182/blood.V116.21.110.110
Published: 2010
Journal Articles

High Antileukemic Efficacy and Shortened Neutropenia of Dose-Dense Induction (Sequential-HAM Followed by Pegfilgrastim) in Primary Acute Myeloid Leukemia - Results of a Pilot Study of the German AML-CG.

Jan Braess, MD, PhD, Karsten Spiekermann, MD, PhD, Christian Buske, MD, PhD, Peter Staib, MD, PhD, Wolf-Dieter Ludwig, MD, PhD, Andreas Gruneisen, MD, Christa Sauerland, PhD, Michael Unterhalt, MD, PhD, Michael Fiegl, MD, Bernhard Wormann, MD, PhD, Wolfgang Kern, MD, PhD, Achim Heinicke, PhD, Wolfgang Berdel, MD, PhD, Thomas Büchner, MD, PhD, Wolfgang Hiddemann, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 295.
https://doi.org/10.1182/blood.V110.11.295.295
Published: 2007
Journal Articles

The Follicular Lymphoma International Prognostic Index (FLIPI) Predicts Treatment Outcome in Patients with Advanced Stage Follicular Lymphoma Treated Front-Line with Rituximab and the Combination of Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP).

Christian Buske, MD, Eva Hoster, MSc, Martin Dreyling, MD, Joerg Hasford, MD, Michael Unterhalt, MD, PhD, Wolfgang Hiddemann, MD, PhD, On behalf of the German Low Grade Lymphoma Study Group (GLSG)
Journal: Blood
Blood (2005) 106 (11): 925.
https://doi.org/10.1182/blood.V106.11.925.925
Published: 2005